Roche Xeloda Medicare Part B Reimbursement Raised To 90% Of AWP
Roche's oncologic Xeloda will be reimbursed at 90% of the average wholesale price under Medicare Part B
Roche's oncologic Xeloda will be reimbursed at 90% of the average wholesale price under Medicare Part B